Lubrizol Corporation's LifeSciences Expands Manufacturing At Bethlehem, Pennsylvania, Production Center
04/27/2016
The 18,000 square foot capacity will include both sterile and non-sterile space with complete lyophilization and filling operations. Among other things, the facility will be tailored for nano-milling and other complex processes.
"As part of our plans for continued growth in this market, we have accelerated the commercial expansion plans at Particle Sciences. The work has already begun, and we plan to be operational in early 2017 with some of the capacity already spoken for by clients with whom we are currently developing products," explains Mark Mitchnick, LifeSciences' Chief Medical Officer and Particle Sciences' CEO.
According to company officials, Particle Sciences has developed special expertise in particulates and drug eluting devices. Over the last several years it has taken multiple products into the clinic on behalf of its clients and has a busy 2016 schedule of clinical trial material production in place.
"While the general contract manufacturing organization (CMO) industry has gone through considerable consolidation around standard dosage forms, LifeSciences has focused on complex processes such as nano-milling, high pressure homogenization, extrusion and micro-particle fabrication. We are clearly the leader in these areas with significant technology and infrastructure advantages. This current multi-million-dollar expansion further demonstrates our commitment and fills a gap in the global CMO space," Mitchnick adds.
Deb Langer, Vice President/General Manager of Lubrizol LifeSciences comments, "Along with expansion at several of our medical device manufacturing facilities, the addition of commercial manufacturing at Particle Sciences keeps us right on track as we grow Lubrizol LifeSciences into the premier pharmaceutical CDMO. Working closely with our clients, we leverage our deep material sciences expertise, global supply chain and operational excellence in the increasingly demanding pharmaceutical and medical device industries. We have penned multiple manufacturing and partnering agreements so far and look to enter into many more. Our corporate strength affords us a unique ability to structure such relationships."
Project Announcements
Northland Corporation Expands Greenville, Michigan, Operations
08/29/2024
Swedish Match Expands Daviess County, Kentucky, Operations
08/29/2024
Ardent Mills Expands Commerce City, Colorado, Production Operations
08/29/2024
Paul Mueller Company Expands Springfield, Missouri, Manufacturing Operations
08/29/2024
Nashville Wire Products Expands McEwen, Tennessee, Operations
08/28/2024
Crusoe Energy Systems Plans Tulsa, Oklahoma, Manufacturing Operations
08/27/2024
Most Read
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
What the Latest EPA PFAS Rule Means for Site Due Diligence
Q3 2024
-
Semiconductors’ fragile relationship with water may be tested
Q3 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
Mitigating Site Risks for Industrial Projects
Q3 2024